Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal Oniris

Home page

Ariza Juan Manuel

Assessment of the effectiveness of a new footbath biocide and the best management practices for the prevention and treatment of the bovine digital dermatitis in dairy cows

Abstract :

The aim of the PhD thesis was to assess the effectiveness of a promising original disinfectant product to decrease the prevalence of digital dermatitis (DD) in dairy herds. This product should be acceptable for farmers, not toxic both for human and the environment and finally allow a rational use of antibiotics. A first part consisted in a meta-analysis of the existing literature about the effectiveness of collective treatments on the healing and prevention of DD lesions. This metaanalysis, besides revealing weak evidence for supporting collective treatment, allowed us to highlight the drawbacks to avoid for our further clinical trial. In a second step, prior to the clinical trial, we assessed both in vitro and in vivo the impact of organic matter and slurry on the efficacy of the disinfectant. This step, rarely conducted for other products, led to determine the most appropriate renewal rate for the footbath under field conditions. A third and last part was devoted to a clinical trial, under good clinical practices, to assess both healing and preventive effect of different regimes of the new disinfectant in comparison to a placebo group, using a split footbath allowing to treat one side of the cow, this latter being, therefore, its own control. The effectiveness was assessed through (i) the evolution over time of DD lesions using survival analysis and (ii) through the description over time of the microbiota found in feet skin biopsies performed before and after treatment using 16s rRNA analysis. The results reported mainly a healing effect of the disinfectant and confirmed the need for a global approach including other risk factors such as hygiene and concomitant individual treatments, to control this multifactorial disease

Key words :

Dairy cow, Digital dermatitis, Epidemiology, Meta-analysis, Clinical trial, Microbiota